Historical record - last NADAC effective date: 6/19/2024
Product Information
LIDOCAN V 5% PATCH is a generic product labeled by PureTek Corporation, priced at $1.9793 per EA under NDC 59088090954. Its NADAC has been published 8 times since May 1, 2024.
FDA first approved this application on Apr 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
PureTek CorporationNDC
59088090954
Classification
Generic
Dosage Form
PATCH
Route
TOPICAL
Effective Date
6/19/2024
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA209190FDA Approved
4/30/2020
TE Code
AB
On Market Since
5/14/2020
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAN V 5% PATCH has been published 8 times since May 1, 2024, and over the history we have for it it has risen 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9793 per EA |
|---|---|
| All-time high | $1.9793 (Jun 19, 2024) |
| All-time low | $1.7004 (May 1, 2024) |
| Median price | $1.7636 |
| Average price | $1.7669 |
| Largest weekly change | +12.2% (Jun 19, 2024) |
| Weeks tracked | 8 |
| Tracking since | May 1, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+16.4%
Last surveyed Jun 19, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PureTek Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine 5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAN V 5% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAN V 5% PATCH, manufactured by PureTek Corporation, is $1.9793 per EA (NDC 59088090954), effective Jun 19, 2024.
How has the price of LIDOCAN V 5% PATCH changed over time?
Over the history we have for it, the NADAC for LIDOCAN V 5% PATCH has risen 16.4%. It has been tracked across 8 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAN V 5% PATCH?
Since May 1, 2024, the NADAC for LIDOCAN V 5% PATCH has ranged from a low of $1.7004 (May 1, 2024) to a high of $1.9793 (Jun 19, 2024), with a median of $1.7636 per EA.
Are there cheaper alternatives to LIDOCAN V 5% PATCH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE 5% PATCH, is $1.9418 per EA — about 2% below LIDOCAN V 5% PATCH.
Who manufactures LIDOCAN V 5% PATCH?
LIDOCAN V 5% PATCH (NDC 59088090954) is labeled by PureTek Corporation, and CMS classifies it as a generic product.